Which hedge funds own ARWR? ARROWHEAD PHARMACEUTICALS IN, Q2 2026 13F holders
Healthcare · Open on the interactive board
9 of the hedge funds tracked by WhaleCreep disclosed a position in ARWR (ARROWHEAD PHARMACEUTICALS IN) in their Q2 2026 13F filings, worth $250.7m in total. The largest holder by portfolio weight is Holocene Advisors at 0.2% of its book. 4 managers opened a new position this quarter: Holocene Advisors, Brevan Howard Capital Management, Millennium Management, Polen Capital Management. 2 exited: Bridgewater Associates, Farallon Capital Management.
9tracked managers holding
4opened this quarter
2exited this quarter
Which hedge funds hold ARWR? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Holocene Advisors | Q2 2026 | 0.2% | $90.2m | 1,106,177 | – | new |
| Brevan Howard Capital Management | Q2 2026 | 0.1% | $4.8m | 58,923 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.1% | $38.2m | 468,921 | -55% | reduced |
| Woodline Partners | Q2 2026 | 0.1% | $16.3m | 200,184 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $35.2m | 431,560 | -64% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $24.9m | 305,031 | 70% | added |
| WCM Investment Management | Q2 2026 | 0.0% | $13.8m | 171,232 | -0% | held |
| Millennium Management | Q2 2026 | 0.0% | $26.8m | 329,337 | – | new |
| Polen Capital Management | Q2 2026 | 0.0% | $538.9k | 6,612 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Bridgewater Associates | 0.9% | $6.0m |
| Farallon Capital Management | 0.0% | $990.7k |
How has hedge fund ownership of ARWR changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 9 | $250.7m |
| Q1 2026 | 8 | $186.1m |
| Q4 2025 | 4 | $40.9m |
| Q3 2025 | 2 | $35.0m |
| Q2 2025 | 2 | $12.0m |
| Q1 2025 | 3 | $8.2m |
| Q4 2024 | 4 | $35.0m |
| Q3 2024 | 5 | $34.1m |
| Q2 2024 | 3 | $34.3m |
| Q1 2024 | 3 | $24.3m |
| Q4 2023 | 6 | $82.4m |
| Q3 2023 | 6 | $85.1m |
| Q2 2023 | 7 | $95.0m |
| Q1 2023 | 6 | $98.1m |
| Q4 2022 | 5 | $125.7m |
| Q3 2022 | 7 | $129.2m |
Counts every tracked manager that disclosed ARWR in that quarter's filing, including managers that have since stopped filing.